Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells
Osteoclasts are a driver of a vicious bone-destructive cycle with breast cancer cells. Here, we examined whether this vicious cycle can be altered into a beneficial one by activating Wnt signaling with its activating agent, BML284. The conditioned medium, derived from Wnt-activated RAW264.7 pre-oste...
Saved in:
Main Authors: | Ke-Xin Li, Xun Sun, Bai-Yan Li, Hiroki Yokota |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/6fe5fef72a444a3ab14d265d934101da |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bone resorptive activity of osteoclast-like cells generated in vitro by PEG-induced macrophage fusion
by: Murillo,Andrea, et al.
Published: (2010) -
Punicalin Attenuates Breast Cancer-Associated Osteolysis by Inhibiting the NF-κB Signaling Pathway of Osteoclasts
by: Tao Li, et al.
Published: (2021) -
IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors
by: Qian Jin, et al.
Published: (2021) -
Flavonoids isolated from Tridax procumbens (TPF) inhibit osteoclasts differentiation and bone resorption
by: Mamun,Md. Abdullah Al, et al.
Published: (2015) -
Modulation of in vitro Osteoclast Activity Mediated by Different Doses of Parathyroid Hormone
by: Ginani,Fernanda, et al.
Published: (2017)